Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00321815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2 Trial Of Erlotinib With Or Without PF-3512676 For The Treatment Of Patients With Advanced EGFR-Positive Non-Small Cell Lung Cancer After Failure Of At Least One Prior Chemotherapy Regimen
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the efficacy and safety of PF-3512676 administered in combination with erlotinib in patients with advanced EGFR-positive non-small cell lung cancer after failure of at least one prior chemotherapy regimen.
Study identification
- NCT ID
- NCT00321815
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 43 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2006
- Primary completion
- May 31, 2010
- Completion
- May 31, 2010
- Last update posted
- Dec 22, 2010
2006 – 2010
United States locations
- U.S. sites
- 35
- U.S. states
- 14
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Daphne | Alabama | 36526 | — |
| Pfizer Investigational Site | Huntsville | Alabama | 35805 | — |
| Pfizer Investigational Site | Mobile | Alabama | 36608 | — |
| Pfizer Investigational Site | Corona | California | 92879 | — |
| Pfizer Investigational Site | Glendora | California | 91741 | — |
| Pfizer Investigational Site | Greenbrae | California | 94904 | — |
| Pfizer Investigational Site | Pasadena | California | 91105 | — |
| Pfizer Investigational Site | Pomona | California | 91767 | — |
| Pfizer Investigational Site | Rancho Cucamonga | California | 91730 | — |
| Pfizer Investigational Site | San Mateo | California | 94402 | — |
| Pfizer Investigational Site | West Covina | California | 91790 | — |
| Pfizer Investigational Site | Norwalk | Connecticut | 06856 | — |
| Pfizer Investigational Site | Deerfield Beach | Florida | 33442 | — |
| Pfizer Investigational Site | Melbourne | Florida | 32901 | — |
| Pfizer Investigational Site | Miami | Florida | 33136 | — |
| Pfizer Investigational Site | Munster | Indiana | 46321 | — |
| Pfizer Investigational Site | Mason City | Iowa | 50401 | — |
| Pfizer Investigational Site | Crestview Hills | Kentucky | 41017 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40202 | — |
| Pfizer Investigational Site | Bridgeton | Missouri | 63044 | — |
| Pfizer Investigational Site | Chesterfield | Missouri | 63017 | — |
| Pfizer Investigational Site | Kirkwood | Missouri | 63122 | — |
| Pfizer Investigational Site | Somerville | New Jersey | 08876 | — |
| Pfizer Investigational Site | New York | New York | 10016 | — |
| Pfizer Investigational Site | Stony Brook | New York | 11794 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45209 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45219 | — |
| Pfizer Investigational Site | Fairfield | Ohio | 45014 | — |
| Pfizer Investigational Site | Hershey | Pennsylvania | 17033-0850 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Pfizer Investigational Site | Philadephia | Pennsylvania | 19104 | — |
| Pfizer Investigational Site | Kingsport | Tennessee | 37660 | — |
| Pfizer Investigational Site | Dallas | Texas | 75230 | — |
| Pfizer Investigational Site | Dallas | Texas | 75246 | — |
| Pfizer Investigational Site | Dalls | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00321815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2010 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00321815 live on ClinicalTrials.gov.